← FDA DRUG APPROVALS

FDA ANDA · ANDA089405

TENCON

Sponsor: MALLINCKRODT

APPLICATION
ANDA089405
TYPE
ANDA
ORIGINAL APPROVAL
1990-05-15
LATEST ACTION
1996-11-14
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

TENCONDiscontinued
ACETAMINOPHEN 650MG, BUTALBITAL 50MG · CAPSULE · ORAL

Approval history

1996-11-14Labeling · Supplement 9AP
1996-08-30Manufacturing (CMC) · Supplement 8AP
1994-09-29Manufacturing (CMC) · Supplement 7AP
1994-06-15Labeling · Supplement 6AP
1994-02-16Labeling · Supplement 5AP
1992-05-05Manufacturing (CMC) · Supplement 3AP
1992-04-16Labeling · Supplement 4AP
1991-05-20Labeling · Supplement 2AP
1990-05-15OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →